- A healthy gut We have known for a long time that our digestive system is home to billions of tiny microbes that help us digest our food properly. We are even encouraged to look…
- Graft vs Host Disease (GvHD) is a common complication for many patients during their recovery after a stem cell transplant. It’s caused by small differences between the new…
- Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem…
- Daniel Gibson, Head of Innovation and Commercialisation talks about the advancements in cellular therapy research, and how we are overcoming critical issues in the supply of…
- This week, the NHS released a long-term plan setting out its priorities for the service over the next ten years. This followed the government’s announcement to increase NHS…
- Jonathan in our patient services team discusses emerging treatments for cancer, using cell therapy and new ‘super cells’. When developing a new cancer treatment, one of the most…
- After new findings from Anthony Nolan’s Patient/Donor project have been published, Jonathan from our Patient Services team looks at how new technology is helping us understand…
- After the news that the Scottish Medicine Consortium has recommended letermovir (Prevymis) for routine use on the NHS in Scotland, Bradley from our Policy and Public Affairs team…
- Young people have a very mixed understanding of what stem cell donation involves. In this blog, Anthony Nolan’s Chief Executive Henny Braund explains how new guidelines from the…
- Daniel Gibson, Head of Innovation and Commercialisation talks about the importance of securing the right material for research, and how Anthony Nolan can support pioneering…